Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

被引：0
|
作者：
Giovanni Fucà
Giulia Galli
Marta Poggi
Giuseppe Lo Russo
Claudia Proto
Martina Imbimbo
Milena Vitali
Monica Ganzinelli
Claudia Lanti
Giuliano Molino
Fabiano Stangoni
Nicoletta Zilembo
Filippo de Braud
Marina Chiara Garassino
Diego Signorelli
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Medical Oncology Department
[2] University of Milan,Department of Oncology and Hemato
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 800
页数：5
相关论文
共 50 条
  • [41] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [42] A Review of Outcomes for Tasmanian Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab on the Access Program
    Conduit, C.
    Black, A.
    Grundy, R.
    Moldovan, C.
    Nott, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 44 - 44
  • [43] The clinical outcome of patients with oligometastatic non-small cell lung cancer treated with first-line immunotherapy
    Miyawaki, Taichi
    Kenmotsu, Hirotsugu
    Doushita, Kousei
    Kodama, Hiroaki
    Nishioka, Naoya
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Ko, Ryo
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2022, 33 : S510 - S510
  • [44] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [45] The low advanced lung cancer inflammation index to predict poor prognosis of patients with metastatic non-small cell lung cancer.
    Lu, Ping
    Ma, Yifei
    Kai, Jindan
    Wang, Jun
    Yin, Zhucheng
    Xu, Hongli
    Li, Xinying
    Liang, Xin
    Wei, Shaozhong
    Liang, Xinjun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab
    Funazo, Tomoko Yamamoto
    Nomizo, Takashi
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Yasuda, Yuto
    Yoshida, Hironori
    Sakamori, Yuichi
    Nagai, Hiroki
    Hirai, Toyohiro
    Kim, Young Hak
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab
    Tomoko Yamamoto Funazo
    Takashi Nomizo
    Hiroaki Ozasa
    Takahiro Tsuji
    Yuto Yasuda
    Hironori Yoshida
    Yuichi Sakamori
    Hiroki Nagai
    Toyohiro Hirai
    Young Hak Kim
    Scientific Reports, 9
  • [48] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [49] Impact of Antibiotics on Outcome of Metastatic Non Small Cell Lung Cancer Patients Treated with Immunotherapy
    Galli, G.
    Poggi, M.
    Fuca, G.
    Imbimbo, M.
    Proto, C.
    Signorelli, D.
    Vitali, M.
    Zilembo, N.
    Ganzinelli, M.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S389 - S389
  • [50] FGFR1-4 mutations are associated with immunotherapy outcomes in patients with non-small cell lung cancer
    Chen, J.
    Yang, H.
    Song, Y.
    Cui, L.
    Zhao, Z.
    Bai, Y.
    Miao, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S1081 - S1081
12345